Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 13Pain, Postoperative 10Neoplasms 8Agnosia 8Multiple Myeloma 7Cancer Pain 5Breast Neoplasms 5Lung Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Head and Neck Neoplasms 3Colonic Neoplasms 3Trigger Finger Disorder 2Lymphoma 2Hodgkin Disease 2Hematologic Neoplasms 2Ganglion Cysts 2De Quervain Disease 2Chronic Pain 2Burkitt Lymphoma 2Acute Pain 2Vomiting 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Strabismus 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Renal Insufficiency 1

Interventions

Cyclophosphamide 7fludarabine phosphate 6venetoclax 5tagraxofusp 5Whole-Body Irradiation 4Mycophenolic Acid 4Methotrexate 4fludarabine 3Thiotepa 3Dexamethasone 3Cyclosporine 3Calcium Dobesilate 3merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Vincristine 2Tacrolimus 2Specimen Handling 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Cytarabine 2Cyclosporins 2Azacitidine 2prednylidene 1lorvotuzumab mertansine 1exifone 1deltacortene 1azathiopurine 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Blastic Plasmacytoid Dendritic Cell Neoplasm × Acetaminophen × Clear all
NCT04681105 2026-01-28

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

City of Hope Medical Center

Phase 1 Completed
13 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Mastocytosis, Systemic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡